Back Pain
📧 Sign up to get email alerts when something new happens for Back Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2020-03-12Clinical Trial Update: Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS) [Phase 4]
A Phase 4 clinical trial evaluating a valve-gated intrathecal drug delivery system for chronic and intractable pain has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-01-25Clinical Trial Update: An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR) [Phase 4]
Phase 4 open-label trial evaluating tapentadol ER in chronic pain patients after conversion from other opioids was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-12Clinical Trial Update: Pain Assessment and Quality of Life in Back Pain Patients: Role of Milnacipran [Phase 3]
Phase 3 trial evaluating milnacipran for back pain has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-10Clinical Trial Update: Analgesic Efficacy of Intravenous Lidocaine for Postoperative Pain Following Adult Spine Surgery [NA]
The study on analgesic efficacy of intravenous lidocaine for postoperative pain after adult spine surgery has been withdrawn from the regist…
-
CLINICAL_TRIALS withdrawal · 2014-01-09Clinical Trial Update: Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning [NA]
A clinical trial investigating cerebrospinal fluid pressure variation with patient positioning in back pain patients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.